References

  1. M. Cyprowski, A. Krajewski, Harmful factors occurring in municipal sewage treatment plants, Occup. Med., 54 (2003) 73–80 (in Polish).
  2. J. Nawrocki, By-products of water oxidation and disinfection, Environ. Prot., 27 (2005) 3–12 (in Polish).
  3. E. Włodarczyk, M. Próba, L. Wolny, Ecotoxicity assessment of stabilized sewage sludge from municipal sewage treatment plant, Civ. Environ. Eng. Rep., 22 (2016) 157–166.
  4. Degrémont (SUEZ) Information Materials, 2017. Available at http://www.degremont.com/en/news/special-topics/whataremicropollutants (in Polish).
  5. C.M. Coetsier, S. Spinelli, L. Lin, B. Roig, E. Touraud, Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?, Environ. Int., 35 (2009) 787–792.
  6. B. Ferrari, N. Paxéus, R.L. Giudice, A. Pollio, J. Garric, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicol. Environ. Saf., 55 (2003) 359–370.
  7. H.W. Leung, T.B. Minh, M.B. Murphy, J.C.W. Lam, M.K. So, M. Martin, P.K.S. Lam, B.J. Richardson, Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China, Environ. Int., 42 (2012) 1–9.
  8. M.D. Sirbu, D. Curseu, M. Popa, A. Achimas-Cadariu, Z. Moldovan, Environmental Risks of Pharmaceuticals and Personal Care Products in Water, Tenth International Water Technology Conference, IWTC10 2006, Alexandria, Egypt, 2006, pp. 1151–1162.
  9. J. Czerwiński, A. Kłonica, J. Ozonek, Residues of pharmaceuticals in the aquatic environment and methods of their removal, JCEEA, 62 (2015) 27–42 (in Polish).
  10. T.A. Ternes, Occurrence of drugs in German sewage treatment plants and rivers, Water Res., 32 (1998) 3245–3260.
  11. A. Zając, I. Kruszelnicka, D. Ginter-Kramarczyk, J. Zembrzuska, The Problem of the Presence of Pharmaceuticals in Sewage, Waterworks and Sewage System, 2012 (in Polish).
  12. E. Felis, K. Miksch, J. Sikora, Occurrence and Disposal Possibilities of Pharmaceuticals in Poland, Conference Materials: VII Polish National Popular Science Session, Environment and Health, Częstochowa, 2005 (in Polish).
  13. N. Lindqvist, T. Tuhkanenb, L. Kronberga, Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Res., 39 (2005) 2219–2228.
  14. N.M. Vieno, T. Tuhkanen, L. Kronberg, Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection, J. Chromatogr. A, 1134 (2006) 101–111.
  15. Z. Moldovan, Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania, Chemosphere, 64 (2006) 1808–1817.
  16. M. Stumpf, T.A. Ternes, R.D. Wilken, S.V. Rodrigues, W. Baumann, Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil, Sci. Total Environ., 225 (1999) 135–141.
  17. J. Dębska, A. Kot-Wasik, J. Namieśnik, Residues of pharmaceutical agents in the environment – transformations, concentrations, determination, Chem. Ecol. Eng., 10 (2003) 723–745 (in Polish).
  18. N. Lindqvist, T. Tuhkanenb, L. Kronberga, Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Res., 39 (2005) 2219–2228.
  19. N.M. Vieno, T. Tuhkanen, L. Kronberg, Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography–tandem mass spectrometry detection, J. Chromatogr. A, 1134 (2006) 101–111.
  20. T. Heberer, Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data, Toxicol. Lett., 131 (2002) 5–17.
  21. Y. Valcárcel, S. González Alonso, J.L. Rodríguez-Gil, R. Romo Maroto, Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceutical in river- and drinking-water of the Madrid Region in Spain, Chemosphere, 82 (2011) 1062–1071.
  22. M. Pedrouzo, F. Borrull, E. Pocurull, R.M. Marcé, Presence of pharmaceuticals and hormones in waters from sewage treatment plants, Water Air Soil Pollut., 217 (2011) 267–281.
  23. E. Vulliet, C. Cren-Olive, M.F. Grenier-Loustalot, Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters, Environ. Chem. Lett., 9 (2011) 103–114.
  24. A. Zgoła-Grześkowiak, Application of DLLME to isolation and concentration of non-steroidal anti-inflammatory drugs in environmental water samples, Chromatographia, 72 (2010) 671–678.
  25. X.F. Zhou, C.M. Dai, Y.L. Zhang, R.Y. Surampalli, T.C. Zhang, A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China, Environ. Monit. Assess., 173 (2011) 45–53.
  26. Y. Zhang, S.U. Geißen, C. Gal, Carbamazepine and Diclofenac: Removal in Wastewater Treatment Plants and K. Sosnowska, K. Styszko-Grochowiak and J. Gołaś, Drugs in the Environment – Sources, Transformations, Threats, Conference Materials: Cracow Conference of Young Scholars, Cracow, 2009, pp. 395–404.
  27. B. Czech, Removal of pharmaceuticals from water and wastewater using adsorption and photocatalytic methods, Adsorb. Catal. Selected Technol. Environ., 2 (2012) 453–466 (in Polish).
  28. J. Rzepa, Determination of Pharmaceuticals and Pesticides in Surface Waters, ed. K.B. Głód, Ed., Advances in Chromatography, Publishing House of the University of Podlasie, Siedlce, 2009, pp. 67–77 (in Polish).
  29. E. Felis, K. Miksch, J. Sikora, Occurrence and Disposal Possibilities of Pharmaceuticals in Poland, Conference Materials: VII Polish National Popular Science Session, Environment and Health, Czestochowa, 2005 (in Polish).
  30. L.F. Delgado, C. Dorandeu, B. Marion, C. Gonzalez, V. Faucet- Marquis, S. Schetrite, C. Albasi, Removal of a cytostatic drug by a membrane bioreactor, Desal. Water Treat., 9 (2009) 112–118.
  31. J.L. Sotelo Sancho, A.R. Rodríguez, S.Á. Torrellas, J.G. Rodríguez, Removal of an emerging pharmaceutical compound by adsorption in fixed bed column, Desal. Water Treat., 45 (2012) 305–314.
  32. G.W. Schwikkard, An Investigation of Advanced Oxidation Processes in Water Treatment, Ph.D. Thesis, University of Natal, Durban, 2001.
  33. B. Kasprzyk-Hordern, A. Dąbrowska, N. Vieno, L. Kronberg, J. Nawrocki, Occurrence of acidic pharmaceuticals in the Warta River in Poland, Anal. Chem., 52 (2007) 289–303.
  34. G. Imfeld, M. Braeckevelt, P. Kuschk, H.H. Richnow, Monitoring and assessing processes of organic chemicals removal in constructed wetlands, Chemosphere, 74 (2009) 349–362.
  35. M. Gross, M. Petrović, D. Barceló, Development of a multi-residue analytical methodology based on liquid chromatography–tandem mass spectrometry (LC–MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters, Talanta, 70 (2006) 678–690.
  36. M. Hijosa-Valsero, V. Matamoros, R. Sidrach-Cardona, J. Martín- Villacorta, E. Bécares, J.M. Bayona, Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters, Water Res., 44 (2010) 3669–3678.
  37. C. Tixier, H.P. Singer, S. Oellers, S. Müller, Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters, Environ. Sci. Technol., 37 (2003) 1061–1068.
  38. Company Information Materials Malvern, Instrukcja Malvern Mastersizer 3000, 2017. Available at www.apinstruments.pl
  39. J. Bodycomb, Advanced Laser Diffraction Theory, HORIBA Scientific, 2012. Available at https://www.slideshare.net/HORIBA/advanced-laser-diffraction-theory
  40. U. Sadowska, The importance of bioindication in water ecotoxicology, Studies Ecologiae et Bioethicae, UKSW, 10 (2012) 33–52.
  41. Test No. 202: Daphnia sp. Acute Immobilisation Test, OECD Guidelines for the Testing of Chemicals, Section 2: Effects on Biotic Systems, 2004.
  42. ISO 6341:2012, Water Quality – Determination of the Inhibition of the Mobility of Daphnia magna Straus (Cladocera, Crustacea) – Acute Toxicity Test, 2012.
  43. DAPHTOXKIT FTM MAGNA Test Instructions for Use, Crustacean Toxicity Screening Test for Freshwater MicroBioTests Inc., Access Date 25.07.2015, Available at www.microbiotests.be/SOPs/Daphtoxkit%20magna%20F%20SOP%20%20A5.pdf
  44. N. Taoufik, W. Boumya, M. Achak, M. Sillanpää, N. Barka, Comparative overview of advanced oxidation processes and biological approaches for the removal pharmaceuticals, J. Environ. Manage., 288 (2021) 112404, doi: 10.1016/j.jenvman.2021.112404.
  45. J. Kazimierowicz, M. Dębowski, M. Zieliński, Effect of pharmaceutical sludge pre-treatment with Fenton/Fentonlike reagents on toxicity and anaerobic digestion efficiency, Int. J. Environ. Res. Public Health, 20 (2023) 271, doi: 10.3390/ijerph20010271.
  46. L. Stępniak, U. Kępaand E. Stańczyk-Mazanek, The influence of high intensity ultrasonic field on the removal of organic compounds from water, Desal. Water Treat., 5 (2009) 29–33.
  47. J. Hartmann, P. Bartels, U. Mau, Degradation of the drug diclofenac in water by sonolysis in presence of catalysts, Chemosphere, 70 (2008) 453–461.
  48. V. Belgiorno, L. Rizzo, D. Fatta, Review on endocrine disruptingemerging compounds in urban wastewater: occurrence and removal by photocatalysis and ultrasonic irradiation for wastewater reuse, Desal. Water Treat., 215 (2007) 166–176.
  49. A. Antoniadis, I. Poulios, E. Nikolakaki, D. Mantzavinos, Sonochemical disinfection of municipal wastewater, J. Hazard. Mater., 146 (2007) 492–495.
  50. V. Naddeo, V. Belgiorno, R.M.A. Napoli, Behaviour of natural organic matter during ultrasonic irradiation, Desal. Water Treat., 210 (2007) 175–182.
  51. V. Naddeo, S. Meric, D. Kassinos, V. Belgiorno, M. Guida, Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation, Water Res., 43 (2009) 4019–4027.
  52. V. Naddeo, M. Landi, V. Belgiorno, R.M.A. Napoli, Wastewater disinfection by combination of ultrasound and ultraviolet irradiation, J. Hazard. Mater., 168 (2009) 925–929.
  53. V. Naddeo, V. Belgiorno, M. Landi, T. Zarra, R.M.A. Napoli, Effect of sonolysis on waste activated sludge solubilisation and anaerobic biodegradability, Desal. Water Treat., 249 (2009) 762–767.
  54. A. Ziylan, S. Dogan, S. Agopcan, R. Kidak, V. Aviyente, N.H. Ince, Sonochemical degradation of diclofenac: by-product assessment, reaction mechanisms and environmental considerations, Environ. Sci. Pollut. Res., 21 (2014) 5929–5939.
  55. M. Petkovšek, M. Zupanc, M. Dular, T. Kosjek, E. Heath, B. Kompare, B. Širok, Rotation generator of hydrodynamic cavitation for water treatment, Sep. Purif. Technol., 10 (2013) 415–423.
  56. V. Naddeo, D. Ricco, D. Scannapieco, V. Belgiorno, Degradation of antibiotics in wastewater during sonolysis, ozonation, and their simultaneous application: operating conditions effects and processes evaluation, Int. J. Photoenergy, 2012 (2012) 624270, doi: 10.1155/2012/624270.
  57. M. Zupanc, T. Kosjek, M. Petkovšek, M. Dular, B. Kompare, B. Širok, Ž Blažeka, E. Heath, Removal of pharmaceuticals from wastewater by biological processes, hydrodynamic cavitation and UV treatment, Ultrason. Sonochem., 20 (2013) 1104–1112.
  58. E. Nie, M. Yang, D. Wang, X. Yang, X. Luo, Z. Zheng, Degradation of diclofenac by ultrasonic irradiation: kinetic studies and degradation pathways, Chemosphere, 113 (2014) 165–170.
  59. H. Yu, E. Nie, J. Xu, S. Yan, W.J. Cooper, W. Song, Degradation of diclofenac by advanced oxidation and reduction processes: kinetic studies, degradation pathways and toxicity assessments, Water Res., 47 (2013) 1909–1918.
  60. G. Weilin, Sonochemical degradation of the antibiotic cephalexin in aqueous solution, Water SA, 36 (2010) 651–654.
  61. A.H. Mahavi, Application of ultrasonic technology for water and wastewater treatment, Iran. J. Public Health, 38 (2009) 1–17.
  62. M. Cleuvers, Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid, Ecotoxicol. Environ. Saf., 59 (2004) 309–315.
  63. T. Haap, R. Triebskorn, H.R. Köhler, Acute effects of diclofenac and DMSO to Daphnia magna: immobilisation and hsp70-induction, Chemosphere, 73 (2008) 353–359.
  64. B. Czech, I. Jośko, P. Oleszczuk, Ecotoxicological evaluation of selected pharmaceuticals to Vibrio fischeri and Daphnia magna before and after photooxidation process, Ecotoxicol. Environ. Saf., 104 (2012) 247–253.
  65. D. Barceló, M. Petrovic, J. Armengol, The Ebro River Basin, Springer Science & Business Media, 2011, p. 230.
  66. K. Nosek, Analysis of Selected Pharmaceuticals as Emerging Pollutants of the Aquatic Environment, Doctoral Dissertation, AGH, Krakow, 2014 (in Polish).
  67. K. Fent, A.A. Weston, D. Caminada, Ecotoxicology of human pharmaceuticals, Aquat. Toxicol., 76 (2006) 122–159.
  68. L.H.M.L.M. Santos, A.N. Araújo, A. Fachini, A. Pena, C. Delerue-Matos, M.C.B.S.M. Montenegro, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater., 175 (2010) 45–95.
  69. B. Ferrari, N. Paxéus, R.L. Giudice, A. Pollio, J. Garric, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicol. Environ. Saf., 55 (2003) 359–370.
  70. J. Oaks, M. Gilbert, M. Virani, R. Watson, C. Meteyer, B. Rideout, H. Shivaprasad, S. Ahmed, M. Chaudhry, M. Arshad, S. Mahmood, A. Ali, A. Khan, Diclofenac residues as the cause of vulture population decline in Pakistan, Nature, 427 (2004) 630–633.
  71. J. Schwaiger, H. Ferling, U. Mallow, H. Wintermayr, R.D. Negele, Toxic effects of the non-steroidal antiinflammatory drug diclofenac: Part I: histopathological alterations and bioaccumulation in rainbow trout, Aquat. Toxicol., 68 (2004)141–150.